Eclipsys posts revenue gains in first quarter

Eclipsys Corp. recorded a 20 percent gain in revenues in the first quarter, but was unable to cut into its net loss.

Revenues increased to $68.4 million, compared with $56.8 million in the first quarter of 2003. The company also posted a net loss of $13.1 million, compared with a net loss of $13 million in the year-ago quarter.

Eclipsys CFO Robert J. Colletti said first-quarter revenues and earnings "are in line" with company expectations, adding that Eclipsys' cash position "remains strong and we are pleased with our improvement in our days sales outstanding."

Eclipsys President and CEO Paul L. Ruflin said the company continues to "concentrate on executing our strategies and are pleased with the progress we have made. We have made significant progress on advancing our technology platform and software products."

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.